Products & Services · Year Three

Multi-line and other specialty — Year Three

Arch Capital Group Multi-line and other specialty — Year Three remained flat by 0.0% to 11.0% in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from 11.0% to 11.0%.

Analysis

StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ4 2018
Last reportedQ4 2025

How to read this metric

Significant changes in Year Three development may indicate prior misestimation of claim severity or frequency.

Detailed definition

This metric represents the loss development or claims activity specifically for the third year following the inception o...

Peer comparison

Standard component of loss development triangles; peers report this as 'Development Year 3'.

Metric ID: acgl_segment_multi_line_and_other_specialty_year_three

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value11%10.9%11.3%11%11%
QoQ Change-0.9%+3.7%-2.7%+0.0%
YoY Change-0.9%+3.7%-2.7%+0.0%
Range10.9%11.3%
CAGR+0.0%
Avg YoY Growth+0.0%
Median YoY Growth-0.5%

Frequently Asked Questions

What is Arch Capital Group's multi-line and other specialty — year three?
Arch Capital Group (ACGL) reported multi-line and other specialty — year three of 11.0% in Q4 2025.
How has Arch Capital Group's multi-line and other specialty — year three changed year-over-year?
Arch Capital Group's multi-line and other specialty — year three decreased by 0.0% year-over-year, from 11.0% to 11.0%.
What does multi-line and other specialty — year three mean?
Claims activity and loss development during the third year of the underwriting period.